Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel
Wael Al Mahmeed, Nader Lessan(Imperial College London Diabetes Centre), Yajnavalka Banerjee(Mohammed Bin Rashid University of Medicine and Health Sciences), Ali A. Rizvi(Emory University), Su‐Yen Goh(Singapore General Hospital), Khalid Al‐Rasadi(Sultan Qaboos University Hospital), Raul D. Santos(Hospital Israelita Albert Einstein), Massimo Galia(University of Palermo), Manfredi Rizzo(Department of Health), Peter P. Tóth(University of Illinois Urbana-Champaign), Νικόλαος Παπάνας(Democritus University of Thrace), Francesco Cosentino(University of Zurich), Anca Pantea Stoian(University of Bucharest), Péter Kempler(University College London), Antonio Ceriello(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 48
Related Papers
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
|European Heart Journal|2013|1.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited
|Arteriosclerosis Thrombosis and Vascular Biology|2004|1.4k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|714
Complications of Diabetes 2017
|Journal of Diabetes Research|2018|644